Literature DB >> 26019209

Performance Characteristics of Xpert Flu/RSV XC Assay.

Elena B Popowitch1, Melissa B Miller2.   

Abstract

The Xpert Flu/RSV XC assay was compared to laboratory-developed tests (LDTs) (n = 207) and the Xpert Flu assay (n = 147) using archived nasopharyngeal swabs. The percentages of positive agreements with LDTs were 97.8% for influenza A, 97.2% for influenza B, and 89.3% for RSV. The sensitivity of influenza detection was improved with the Xpert Flu/RSV XC assay compared to the Xpert Flu assay.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Year:  2015        PMID： 26019209      PMCID： PMC4508419          DOI： 10.1128/JCM.00972-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Simultaneous detection of influenza viruses A and B using real-time quantitative PCR.

Authors:  L J van Elden; M Nijhuis; P Schipper; R Schuurman; A M van Loon
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  Can newly developed, rapid immunochromatographic antigen detection tests be reliably used for the laboratory diagnosis of influenza virus infections?

Authors:  James J Dunn; Christine C Ginocchio
Journal:  J Clin Microbiol       Date:  2014-10-01       Impact factor: 5.948

3.  Retrospective and prospective verification of the Cepheid Xpert influenza virus assay.

Authors:  Elena B Popowitch; Elaine Rogers; Melissa B Miller
Journal:  J Clin Microbiol       Date:  2011-07-20       Impact factor: 5.948

4.  Role of rapid immunochromatographic antigen testing in diagnosis of influenza A virus 2009 H1N1 infection.

Authors:  David F Welch; Christine C Ginocchio
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

5.  Comparative evaluation of the Nanosphere Verigene RV+ assay and the Simplexa Flu A/B & RSV kit for detection of influenza and respiratory syncytial viruses.

Authors:  Kevin Alby; Elena B Popowitch; Melissa B Miller
Journal:  J Clin Microbiol       Date:  2012-11-14       Impact factor: 5.948

6.  Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults.

Authors:  L J R van Elden; A M van Loon; A van der Beek; K A W Hendriksen; A I M Hoepelman; M G J van Kraaij; P Schipper; M Nijhuis
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

7.  Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status.

Authors:  Gonçalo Matias; Robert Taylor; François Haguinet; Cynthia Schuck-Paim; Roger Lustig; Vivek Shinde
Journal:  Influenza Other Respir Viruses       Date:  2014-06-27       Impact factor: 4.380
  7 in total
  12 in total

Review 1.  The Drift in Molecular Testing for Influenza: Mutations Affecting Assay Performance.

Authors:  Kathleen A Stellrecht
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

2.  Comparison of the Xpert Flu/RSV XC and Xpress Flu/RSV Assays.

Authors:  Elena B Popowitch; Melissa B Miller
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

3.  Profile of the Alere i Influenza A & B assay: a pioneering molecular point-of-care test.

Authors:  Hongmei Wang; Jikui Deng; Yi-Wei Tang
Journal:  Expert Rev Mol Diagn       Date:  2018-04-24       Impact factor: 5.225

Review 4.  Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.

Authors:  Cameron Griffiths; Steven J Drews; David J Marchant
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

5.  Comparison of NxTAG Respiratory Pathogen Panel and Anyplex II RV16 Tests for Multiplex Detection of Respiratory Pathogens in Hospitalized Children.

Authors:  Pedro Brotons; Desiree Henares; Irene Latorre; Antonio Cepillo; Cristian Launes; Carmen Muñoz-Almagro
Journal:  J Clin Microbiol       Date:  2016-09-14       Impact factor: 5.948

6.  Comparison of Cepheid Xpert Flu/RSV XC and BioFire FilmArray for Detection of Influenza A, Influenza B, and Respiratory Syncytial Virus.

Authors:  Mark G Wahrenbrock; Scott Matushek; Sue Boonlayangoor; Vera Tesic; Kathleen G Beavis; Angella Charnot-Katsikas
Journal:  J Clin Microbiol       Date:  2016-04-20       Impact factor: 5.948

Review 7.  Laboratory Diagnosis of Respiratory Tract Infections in Children - the State of the Art.

Authors:  Shubhagata Das; Sherry Dunbar; Yi-Wei Tang
Journal:  Front Microbiol       Date:  2018-10-18       Impact factor: 5.640

Review 8.  Sample-to-result molecular infectious disease assays: clinical implications, limitations and potential.

Authors:  Stacy G Beal; Naziheh Assarzadegan; Kenneth H Rand
Journal:  Expert Rev Mol Diagn       Date:  2016-01-11       Impact factor: 5.225

Review 9.  Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection.

Authors:  Ece Egilmezer; Gregory J Walker; Padmavathy Bakthavathsalam; Joshua R Peterson; J Justin Gooding; William Rawlinson; Sacha Stelzer-Braid
Journal:  Rev Med Virol       Date:  2018-08-13       Impact factor: 6.989

10.  Cepheid Xpert® Flu/RSV and Seegene Allplex™ RP1 show high diagnostic agreement for the detection of influenza A/B and respiratory syncytial viruses in clinical practice.

Authors:  Nasir Wabe; Robert Lindeman; Jeffrey J Post; William Rawlinson; Melissa Miao; Johanna I Westbrook; Andrew Georgiou
Journal:  Influenza Other Respir Viruses       Date:  2020-08-20       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.